POSSIBLE ADVERSE EFFECT OF FAILED ADJUVANT CHEMOTHERAPY ON THE PROGNOSIS OF WOMEN RECEIVING CONSECUTIVE CHEMOTHERAPY FOR RECURRENT BREAST-CANCER

被引：5
作者：
DITTRICH, C
JAKESZ, R
PIRICH, K
HAVELEC, L
STEGER, G
SCHLAPPACK, O
KOLB, R
MOSER, K
机构：
[1] VIENNA UNIV,DEPT SURG 1,A-1090 VIENNA,AUSTRIA
[2] VIENNA UNIV,DEPT MED 1,A-1090 VIENNA,AUSTRIA
[3] VIENNA UNIV,INST MED STAT & DOCUMENTAT,A-1090 VIENNA,AUSTRIA
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1987年 / 113卷 / 05期
关键词：
D O I：
10.1007/BF00390044
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：488 / 494
页数：7
相关论文
共 44 条
[1]  
[Anonymous], 1979, WHO HDB REPORTING RE, V48
[2]  
BITRAN JD, 1983, CANCER, V51, P381, DOI 10.1002/1097-0142(19830201)51:3<381::AID-CNCR2820510304>3.0.CO
[3]  
2-Z
[4]   ADJUVANT SYSTEMIC THERAPY FOR RESECTABLE BREAST-CANCER [J].
BONADONNA, G ;
VALAGUSSA, P .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (02) :259-275
[5]   10-YEAR EXPERIENCE WITH CMF-BASED ADJUVANT CHEMOTHERAPY IN RESECTABLE BREAST-CANCER [J].
BONADONNA, G ;
VALAGUSSA, P ;
ROSSI, A ;
TANCINI, G ;
BRAMBILLA, C ;
ZAMBETTI, M ;
VERONESI, U .
BREAST CANCER RESEARCH AND TREATMENT, 1985, 5 (02) :95-115
[6]   COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].
BONADONNA, G ;
BRUSAMOLINO, E ;
VALAGUSSA, P ;
ROSSI, A ;
BRUGNATELLI, L ;
BRAMBILLA, C ;
DELENA, M ;
TANCINI, G ;
BAJETTA, E ;
MUSUMECI, R ;
VERONESI, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410
[7]  
BUZDAR AU, 1981, CANCER, V47, P2798, DOI 10.1002/1097-0142(19810615)47:12<2798::AID-CNCR2820471207>3.0.CO
[8]  
2-T
[9]  
CARTER SK, 1980, CANCER CHEMOTH PHARM, V4, P147
[10]   LONG-TERM SURVIVAL FOLLOWING RELAPSE AFTER 5-FU BUT NOT CMF ADJUVANT BREAST-CANCER THERAPY [J].
CHLEBOWSKI, RT ;
WEINER, JM ;
REYNOLDS, R ;
LUCE, J ;
BULCAVAGE, L ;
BATEMAN, JR .
BREAST CANCER RESEARCH AND TREATMENT, 1986, 7 (01) :23-29
12345